维普中文期刊产品整合服务
203篇 您的检索式:作者名="ALIZADEH R"
    题名 作者 年代 出处 被引量
1Endoscopic retrograde cholangiopancreatography outcome from a single referral center in Iran显示文摘BACKGROUND: Endoscopic retrograde cholangiopancreato- graphy (ERCP) is the first choice for diagnostic evaluation of the pancreatic and biliary tree and can be accompanied by a high diagnostic sensitivity and a poor therapeutic outcome. In the current study, we described our experiences in the indications, findings, and technical success of ERCP in a sample of the Iranian population admitted to a referral center in Iran. METHODS: In a retrospective review database-based study, 780 patients (393 males and 387 females; mean age 57.5 years) who had undergone diagnostic and therapeutic ERCP with the primary diagnosis of hepatobiliary disorder between 2006 and 2008 at Taleghani Hospital in Tehran were reviewed. The key data were demographic characteristics, clinical information, laboratory parameters, as well as post-ERCP complications. RESULTS: A history of cholecystectomy was found in about one-third (36.3%) of participants and 80 (10.3%) out of 780 patients had a previous history of biliary stone. A minority (1.4%) of the patients suffered from hepatobiliary carcinomas, and 11 patients had cirrhosis. The most common clinical manifestations in the patients undergoing diagnostic ERCP were icterus (47.3%), weight loss (31.2%), and dark urine (26.9%). Selective biliary cannulation was technically successful in 87.0% of the patients; however, cannulation failed in 13.0%. The most frequent final diagnosis of ERCP was common bile duct stone that was detected in 40.1% of the patients. The ERCP results in 11.0% of the patients were normal. Regarding appropriate treatment, successful stenting was performed in 43 patients (15.2%). Among post-ERCP complications, pancreatitis was the most adverse event withan incidence rate of 3.3%. Other complications including local bleeding, cholangitis and gastrointestinal perforation, rarely occurred. Post-ERCP pancreatitis was reported in 1.8% of men and 3.6% of women (P=0.120). Pancreatitis was more common in women below 70 years than in those who were older than 70 years (3.6% versus 0.5%; OR: 8.216, P=0.015). This might be due to the more functionally active pancreas in younger women than in the older ones. However, other complications were similar in the two age groups. CONCLUSIONS: Based on our experience, ERCP indications, final diagnosis and related complications are comparatively consistent with those reported in other countries. The most common post-ERCP complication is pancreatitis that is more often observed in younger patients.Amir H Mohammad Alizadeh Esmaeil S Afzali Mirhadi Mousavi Yaghoub Moaddab Mohammad R Zali 2010Hepatobiliary & Pancreatic Diseases International2010,9,4:3
2Identification of Armillaria biological species in Iran 显示文摘Asef M R Goltapeh E M Alizadeh A 2003Fungal Diversity(Kunming)2003,14,:1
3Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia 显示文摘Chao MP Alizadeh AA Tang C Jan M Weissman-Tsukamoto R Zhao F 2011Cancer Res2011,71,4:1
4Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling显示文摘Alizadeh A A Eisen M B Davis R E 2000Nature2000,403,6769:1
5Dynamics of h:e Nucleation on Water Repellent Surfaces 显示文摘ALIZADEH A YAMADA M LI R el al 2012l angmuir2012,28,:1
6CD47 is an adverse prog? nostic factor and therapeutic antibody target on human acute my?eloid leukemia stem cells显示文摘Majeti R Chao MP Alizadeh AA 2009Cell2009,138,2:1
7CD47 is an adverse prog- nostic factor and therapeutic antibody target on human acute mye- loid leukemia stem cells显示文摘Majeti R Chao MP Alizadeh AA 2009Cell2009,138,:1
8Synthesis, structure, and characterization of a new sandwich type arsenotungstocerate, ^12-显示文摘Alizadeh M H Eshtiagh-Hosseini H Khoshnavazi R 2004J Mole Struct2004,688,:1
9CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells 显示文摘Majeti R Chao MP Alizadeh AA 2009Cell2009,138,2:1
10Elevated CRP levels are associated with increased carotid atherosclerosis inde- pendent of visceral obesity显示文摘Alizadeh Dehnavi R de Roos A Rabelink TJ 2008Atherosclerosis2008,200,2:1
11Distinct types of dif- fuse large B cell lymphoma identified by gene expression profiling 显示文摘Alizadeh A A Eisen M B Davis R E 2000Nature2000,403,6769:1
12Prevalence and intensity of hyper glycemia in non-diabetic patients undergoing coronary artery bypass graft surgery with and without cardiopulmonary bypass显示文摘Azarfarin R Alizadeh Asl A 2008Saudi Med J2008,29,9:1
13Genetic diversity of Fusarium proliferatum popula- tions from maize, onion, rice and sugarcane in Iran based on vege- tative compatibility grouping显示文摘ALIZADEH A NIKKHAH M J FOTOUHIFAR K B MOTLAGH E R RAHJOO V 2010The Plant Pathology Journal2010,26,3:1
14Forecasting spot and forward prices in the international freight market显示文摘BATCHELOR R ALIZADEH A VISVIKIS I 2007International Journal of Forecasting2007,23,1:1
15Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling 显示文摘Alizadeh A A Eisen M B Davis R E 2000Nature2000,403,6769:1
16Effect of curing conditions on the service life design of RC structures in the Persian gulf region显示文摘Alizadeh R Ghods P Chini M 2008Journal of Materials in Civil Engineering2008,20,1:1
17Pulmona~r function pa- rameters changes at different altitudes in healthy athletes 显示文摘Ziaee V Alizadeh R Movafegh A 2008Iran J Allergy Asthma Immunol2008,7,:1
18Selective determination of chloramphenicol at trace level in milk samples by the electrode modified with molecularly imprinted polymer显示文摘ALIZADEH T GANJALI M R ZARE M 2012Food Chem_2012,130,:1
19Cd47 is an adverseprognostic factor and therapeutic antibody target on human acutemyeloid leukemia stem cells 显示文摘Majeti R Chao MP Alizadeh AA 2009Cell2009,138,2:1
20Prevalence and intensity of hypergly- cemia in non- diabetic patients undergoing coronary artery bypass graft surgery with and without cardiopulmonary bypass 显示文摘Azarfarin R Alizadeh Asl A 2008Saudi Med J2008,29,9:1
返回顶部 每页显示:
共11页 首页 上一页 第1页 下一页 末页 /11 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费